Seit der Zulassung von Ipilimumab 2011 haben Immuncheckpoint-Inhibitoren (ICI) die Behandlung vieler solider und ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback